Tech Company Financing Transactions
Biogenic Reagents Funding Round
Biogenic Reagents closed a $9.5 million funding round on 8/3/2013. Investors included MVC Capital and private investors.
Transaction Overview
Company Name
Announced On
8/3/2013
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Undisclosed
Investors
MVC Capital (Lead Investor)
Proceeds Purpose
The new round of funding will help prepare the facility to make carbon products for controlling mercury emissions at power plants, CEO James Mennell told the Mining Journal newspaper.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
133 North 1st Ave.
Minneapolis, MN 55401
USA
Minneapolis, MN 55401
USA
Phone
Website
Email Address
Overview
Biogenic Reagents is a producer of low cost, high-performance carbon products made from renewable resources.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Mennell
Chief Financial Officer
Douglas Rohall
Chief Technical Officer
Daniel Despen
President
Enrico Biasetti
VP - Operations
Todd Smrekar
Browse more venture capital transactions:
Prev: 8/3/2013: Citymaps venture capital transaction
Next: 8/3/2013: BioBeats venture capital transaction
Share this article
About Our VC Transactions Data
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs